NASDAQ:ITCI
Delisted

Intra-cellular Therapies Stock Signals

etoro logo Buy ITCI
*Your capital is at risk
$131.87
+0 (+0%)
At Close: Jul 01, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Intra-Cellular Therapies Inc.

General

Signal Type Signal Value Data
Score 0.000 116 days ( -3.92 %
Last Price $131.87 0 %
Performance History
7 Days
$131.87 $131.87
0%
30 Days
$131.87 $131.87
0%
12 Mos
$67.99 $131.87
93.95%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $131.87 - $131.87
Trend - 3 mos 0 % High Width: 0.00000000000013 %
Pred. range - 3 mos $131.87 - $131.87 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jun 30, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Apr 15, 2025 - 53 days
Short MA 3 mos Sell Low Apr 07, 2025 - 59 days
Long MA 3 mos Sell Medium May 16, 2025 - 31 days
Short/Long MA 3 mos Sell Medium May 16, 2025 - 31 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 46.06
Signal Type Signal Value Importance Data
Trend - 12 mos 107.64 % Very High Width: 30.17 %
Pred. range - 12 mos $251.65 - $327.58 High 90.83 % - 148.41 %
Short MA 12 mos Sell Very High Apr 28, 2025 - 45 days
Long MA 12 mos Buy Very High Oct 08, 2024 - 182 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Sell Low Mar 31, 2025 - 64 days
RSI Long Pivot Signal Sell Low Apr 25, 2025 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT INTRA-CELLULAR THERAPIES INC.
Intra-Cellular Therapies
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
6.93% Jun 29
IIIV
$20.09
9.33% Jun 25
JLL
$299.78
6.19% Jun 24
NMRK
$15.02
3.00% Jun 24
X
XMAX
$8.34
9.71% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE